Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Micromet exercises option for Morphotek antibody

Feb. 14, 2007

PEP-005 Topical studied in phase II trial for superficial BCC

Feb. 14, 2007

SIR-Spheres, bevacizumab + chemotherapy studied for metastatic colorectal cancer

Feb. 14, 2007

Nexavar extends survival in advanced hepatocellular carcinoma

Feb. 13, 2007

ViaCell will not advance CB-001 based on phase I findings

Feb. 13, 2007

Apotherapy CD40 research program receives E.U. funding

Feb. 13, 2007

Guidelines devised for photodynamic therapy for nonmelanoma skin cancer

Feb. 13, 2007

BioProgress to inlicense MuGard

Feb. 12, 2007

ABT-737 shows antimyeloma activity alone or in combination in preclinical studies

Feb. 12, 2007

Financing at Proacta to support development of PR-104

Feb. 12, 2007

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...